MedTrace Logo

Community-Driven Cervical Cancer Prevention in Western Kenya

NCT02124252 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 7200

Last updated 2019-04-10

No results posted yet for this study

Summary

There are many challenges to implementation of cervical cancer prevention in resource-limited countries, despite evidence based screening and treatment strategies. The investigators hypothesize that self-collected HPV specimens offered in a community health campaign setting will

Conditions

  • Human Papilloma Virus Infection
  • Carcinoma in Situ of Uterine Cervix

Interventions

BEHAVIORAL

Community-based testing with standard linkage to care

Women will be offered HPV-based cervical cancer screening followed by standard linkage to care for women who test positive (to subdistrict or district hospitals).

BEHAVIORAL

Community-based HPV testing with enhanced linkage to care

Women will be offered HPV-based cervical cancer screening followed by enhanced linkage to care using the strategies determined in partnership with the key stakeholders in the communities.

Sponsors & Collaborators

Principal Investigators

  • Megan J Huchko, MD, MPH · University of California, San Francisco

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
FACTORIAL

Eligibility

Min Age
25 Years
Max Age
65 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-01-31
Primary Completion
2016-10-31
Completion
2019-03-31

Countries

  • Kenya

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02124252 on ClinicalTrials.gov